Paying users zone. Data is covered by hidden.

  • Get to Allergan PLC for $13.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Statement of Comprehensive Income

Difficulty: Beginner

Allergan PLC, Consolidated Statement of Comprehensive Income

USD $ in thousands

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net income (loss) hidden hidden hidden hidden hidden
Foreign currency translation gains (losses) hidden hidden hidden hidden hidden
Net impact of other-than-temporary loss on investment in Teva securities hidden hidden hidden hidden hidden
Impact of Teva Transaction hidden hidden hidden hidden hidden
Unrealized gains (losses), net of tax hidden hidden hidden hidden hidden
Other comprehensive income (loss), net of tax hidden hidden hidden hidden hidden
Comprehensive income (loss) hidden hidden hidden hidden hidden
Comprehensive (income) loss attributable to noncontrolling interest hidden hidden hidden hidden hidden
Comprehensive income (loss) attributable to ordinary shareholders hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18), 10-K (filing date: 2014-02-25).

Item Description The company
Net income (loss) attributable to shareholders The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Allergan PLC's net income (loss) attributable to shareholders increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Comprehensive income (loss) attributable to ordinary shareholders Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Allergan PLC's comprehensive income (loss) attributable to ordinary shareholders increased from 2015 to 2016 but then declined significantly from 2016 to 2017.